Neuroprotection by Sodium Channel Blockade With Phenytoin in an Experimental Model of Glaucoma

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.05-0618
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Phenytoin for Neuroprotection – Authors' Reply

The Lancet Neurology
Neurology
2016English

Marked QRS Complex Abnormalities and Sodium Channel Blockade by Propoxyphene Reversed With Lidocaine.

Journal of Clinical Investigation
Medicine
1989English

Neuroprotection in Glaucoma‑electrophysiology (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

Neuroprotection in Glaucoma – Outstanding Challenges

Acta Ophthalmologica
MedicineOphthalmology
2018English

Pharmacology of Sodium and Calcium Channel Modulation in Neurons: Implications for Neuroprotection

Biochemical Society Transactions
Biochemistry
1995English

Neuroprotection in Glaucoma: Drug-Based Approaches

Optometry and Vision Science
OptometryOphthalmology
2008English

Potassium Channel Activators Differentially Modulate the Effect of Sodium Channel Blockade on Cardiac Conduction

Acta Physiologica
Physiology
2012English

Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model

Journal of Neuroscience
Neuroscience
2019English

Megaloblastic Anaemia Due to Phenytoin Sodium

BMJ
1955English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy